FactEvidence 2
acquiresShionogi
No public evidence summary is available.
Nikkei Asia · BioPharma Dive · 2026-10-06 00:26
View evidence
- MediaNikkei Asia2026-10-06 00:26View source
- MediaBioPharma Dive2026-10-05 23:57View source
Company
IntraBio
Structure of IntraBio
IntraBio
Company
2 connections
ConstraintsRegulation and exposure
OwnershipInvestment and holdings
Relationship began
IntraBioCompany · 2 connections
Layer 1OwnershipInvestment and holdings1
ConstraintsRegulation and exposure1
Relations
Arrows show the direction of the relationship. Filter to focus on a business area.
- Shionogiacquires →IntraBioCompany · ShionogiEvidence 2Fact80%
View evidence
- MediaNikkei Asia2026-10-06 00:26View source
- MediaBioPharma Dive2026-10-05 23:57View source
- Geography · U.S.Evidence 1Fact55%
View evidence
- MediaNikkei Asia2026-10-06 00:26View source
Showing 1 to 2 of 2
Claims
Read the assertion alongside its sources. Expand a row to inspect the evidence.
FactEvidence 1
located inU.S.
No public evidence summary is available.
Nikkei Asia · 2026-10-06 00:26
View evidence
- MediaNikkei Asia2026-10-06 00:26View source
FactEvidence 1
reports sales$68 million USD
No public evidence summary is available.
BioPharma Dive · 2026-10-05 23:57
View evidence
- MediaBioPharma Dive2026-10-05 23:57View source
Showing 1 to 3 of 3
Market and valuation
Valuation data is available on Pro and Research.
Included in ProNot available: Company signals · Financials · Filings · Guidance